Copy Link Print Information

Bimekizumab

(Synonyms: CDP4940; UCB-4940)
1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody) is a humanised monoclonal antibody, can selectively neutralises IL-17A and IL-17F. Both of them are pro-osteogenic with respect to human periosteum-derived cell (hPDC) differentiation. Thus Bimekizumab blocks the inflammation-driven osteogenic differentiation.

For research use only. We do not sell to patients.

  • Purity : 99.44%
  • CAS No.: 1418205-77-2
  • Molecular Weight:147.24 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Bimekizumab
  • Experimental Validation Results for Bimekizumab
  • Experimental Validation Results for Bimekizumab
  • Bimekizumab Chemical Structure
    Bimekizumab Chemical Structure
CAS No.: 1418205-77-2
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Bimekizumab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Bimekizumab

More

All Interleukin Related Isoforms

More

Keywords

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG1 kappa

  • 1/16

    Immobilized IL-17A (136a.a)-17F Heterodimer Protein, Human can bind Bimekizumab. The EC50 for this effect is 16.18 ng/mL.

  • 1/16

    Loaded Bimekizumab on AHC2 biosensor, can bind IL-17A Protein, Human (HEK293, His, HY-P70527) with an affinity constant of <1.000E11 M as determined in BLI assay.

  • Bimekizumab Chemical Structure
    1/16
  • Bimekizumab
  • Immobilized IL-17A (136a.a)-17F Heterodimer Protein, Human can bind Bimekizumab. The EC50 for this effect is 16.18 ng/mL.
  • Loaded Bimekizumab on AHC2 biosensor, can bind IL-17A Protein, Human (HEK293, His, HY-P70527) with an affinity constant of <1.000E11 M as determined in BLI assay.